4
Changes in Ownership
PROCEPT BioRobotics Corp Filed Acc 0001628280-24-043032
EVP, CFO sold 25,000 shares at an average $72.47 ($1,811,653)
- EVP, CFO acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waters Kevin EVP, CFO | 2024-10-15 | Option exercise 10b5-1 | +25,000 | $4.56 | $114,000 | 121,096 | D |
| Waters Kevin EVP, CFO | 2024-10-15 | Sale 10b5-1 | −15,959 | $72.11 | $1,150,803 | 105,137 | D |
| Waters Kevin EVP, CFO | 2024-10-15 | Sale 10b5-1 | −8,115 | $73.02 | $592,557 | 97,022 | D |
| Waters Kevin EVP, CFO | 2024-10-15 | Sale 10b5-1 | −926 | $73.75 | $68,293 | 96,096 | D |
| Derivatives | |||||||
| Waters Kevin EVP, CFO | 2024-10-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 19,160 | D | ||
| Open-market sales · 25,000 sh · avg $72.47 · $1,811,653 | |||||||
Loading xslF345X05/wk-form4_1729196860.xml…